Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

JOINT COMMITTEE ON HEALTH AND CHILDREN díospóireacht -
Thursday, 29 Sep 2005

Cystic Fibrosis Association of Ireland: Presentation.

There will now be a presentation by the Cystic Fibrosis Association of Ireland on the health service needs of people with cystic fibrosis. I welcome Mr. Godfrey Fletcher, chief executive officer, Ms Mary Lane Heneghan, chairperson, and Mr. Carl Rainey, vice-chairperson, of the Cystic Fibrosis Association of Ireland; Dr. Charles Gallagher, chairman of the Medical and Scientific Council, and Mr. Rory Tallon, NEC.

Before commencing, I remind members of the long-standing parliamentary practice to the effect that members should not comment on, criticise or make charges against a person outside the House or any official by name or in such a way as to make him or her identifiable.

Mr. Godfrey Fletcher

We come before the committee to highlight the deficiencies in the current levels of service in cystic fibrosis care. The Cystic Fibrosis Association of Ireland commissioned an external report, The Treatment of Cystic Fibrosis in Ireland: Problems and Solutions 2005, that was launched in February this year. This report identified the following deficiencies. The current staffing for cystic fibrosis is seriously inadequate. It is unbalanced and too thinly distributed over too many, too small units. Compared to basic international recommendations we are understaffed by 438% with 40 full-time staff looking after CF patients in Ireland where the basic international recommendation is 175.

Physical resources fall well below accepted standards with a lack of segregation and isolation facilities for both outpatient and inpatient services. The report states that this is dangerous and creates significant risks of cross infection. There are huge deficiencies in the provision of adult services. This is of special concern because of the steadily increasing proportion of adult patients and the necessary complexity and severity of their condition. There is an approximate 11% increase each year in the adult population. Funding of CF care is unstable and at risk from other pressures. There is no system of accreditation of CF centres.

Cystic Fibrosis is Ireland's most common life threatening genetically inherited disease with one in 20 people carrying the CF gene. There is no current cure for CF. People with CF can accept the constant disability of the disease but they cannot accept the current lack of a properly resourced service that meets basic international standards. The current situation across the country is of great concern. We have fully stretched under resourced paediatric departments with no capacity to take the initial load of patients that could be identified early by a national screening programme. Adult services are being offered by paediatric departments because no adult services are available locally or because of the huge pressure on existing adult units. Outpatient and inpatient services are being provided under internationally unacceptable conditions with a substantial risk of cross infection. There are geographic regions where there is no rudimentary CF service available resulting in patients having to travel long distances for basic procedures.

The association is seeking the support of this committee to implement the recommendations of the Pollock report. The most important recommendations are as follows: urgent action should be initiated to address the dangerously inadequate staffing position — no single unit that was surveyed during June 2005 had 50% of the recommended staffing levels; the designation of a small number of adequately staffed, fully supported, specialist cystic fibrosis centres, with sufficient patients to ensure ready access to a multi-disciplinary team; adult provision outside Dublin should be developed urgently to create a balanced service with broad geographical coverage, thus reducing the excessive burden on St. Vincent's Hospital; all beds for cystic fibrosis patients should be in single rooms with en suite toilet facilities to prevent the transmission of dangerous organisms; the links between the adult and children’s units need to be strengthened, with appropriate arrangements for the transition from child to adult service; a microbiology reference laboratory needs to be established; the establishment of a neonatal screening programme.

All these recommendations can be substantiated by a myriad of other independent reports, the most recent being Standards of Care for Patients with Cystic Fibrosis: A European Consensus, which was published in January 2005. Since the publication of our external report we have been actively campaigning for the implementation of these recommendations. We have made some progress, however slow. A joint multi-disciplinary working group with the HSE was established that was to have completed its work by the end of May. This is now scheduled for completion on 12 October. This working group is focused on designing an acceptable model of care and the securing of funds from the 2006 health budget. It is important that this money is provided for in the forthcoming budget. All stakeholders in this process must proactively drive the process to a timely conclusion.

Emergency funding of €300,000 has been allocated by the HSE to St. Vincent's Hospital — the national adult referral centre — in recurring funding. While this gesture is welcome, it is only one small step towards the provision of basic internationally acceptable services and facilities. I received some disturbing news this morning. We were due to receive a letter from the HSE confirming the appointment of a full-time consultant with this funding but the letter states it will only be a locum consultant. This must be changed. We welcome this month's launch of the national guidelines on hand hygiene and the guidelines on the control of MRSA in hospitals and community settings. Cross infection is potentially life threatening for people with CF and it is important that these guidelines are strictly enforced.

We welcome the progress in lung transplantation in the Mater Hospital where three transplants have now taken place. We look forward to the day when CF lung transplants will take place in Ireland. I implore you, Vice Chairman, and other members of the committee to support our efforts to put right a service that falls well below basic internationally accepted standards. With the committee's assistance we can provide a service of which the nation will be proud. The improvement of services for cystic fibrosis is not a complex issue and can be resolved easily, compared to other services. Funding must be made available from the 2006 and subsequent HSE budgets with an agreed five-year strategy, cast in stone, for the development of CF services. The estimated funding required would be in the region of €9 million to €10 million per annum for additional staffing and €20 million in capital investment for the development and refurbishment of CF units across the country. Since we have the highest incidence of CF in the world, as has been stated by the World Health Organisation, with one of the worst levels of service, we must aspire to become a world leader in CF care.

Thank you very much, Mr. Fletcher. Before I throw the meeting open for questions, I have a few points. You referred to the geographical inequalities. Can you outline where there is a reasonable service here and where the level of such services is unacceptable? As regards the sum of €9 million to €10 million for additional staff, are you talking about consultant, medical or nursing staff?

Mr. Fletcher

I will ask Dr. Charles Gallagher to answer those questions.

It has been shown clearly by the Pollock report, an external review of CF services in Ireland, that nowhere in Ireland do we have an adequate or safe service. We have areas that have no service at all, but nowhere in the country do we have a service that is safe or adequate compared to current care in the UK or elsewhere in Europe. The evidence, unfortunately, is that we have the worst service for cystic fibrosis in Western Europe. Many countries in Eastern Europe have a better service than we do.

The Vice Chairman has raised a very important point concerning staffing needs. The treatment of cystic fibrosis is a totality of care which requires a team approach involving doctors, nurses, physiotherapists, dieticians, social workers and psychologists. The funding to which we referred is to hire the appropriate people in all those areas. The Vice-Chairman mentioned one example. We currently have a total of 3.3 consultants looking after all the people with cystic fibrosis in Ireland, whereas 28 consultants are needed. The same principle applies to nurses, physiotherapists, dieticians and others. We do not have a safe service in any part of Ireland.

It is disturbing to hear such a presentation. We all received the Pollock report but going back over it in such a stark manner presents us with a challenge to try to meet the requirements. Dr. Gallagher said there were regions where there is no service at all, but at another point in the presentation it was stated that there were too many centres. "Too many and too small units" was the term used. Presumably there is a matrix by which to concentrate services and ensure that outreach or access for communities. Perhaps Dr. Gallagher could talk about that.

He concentrated on hospital services but could he also refer to community services and the need for backup? Is that an issue? The staffing requirements are quite considerable. It is extremely difficult to get any information about how our health service is operating because much accountability has been leached out of the system. As regards funding, the HSE is €80 million short on its budget this year. The major hospitals in Dublin are €100 million short. Does Dr. Gallagher have any confidence that this additional money will be forthcoming? What indications does he have from the Minister and from the Department concerning this strategy that clearly must be put in place but requires funding?

One of the main issues has been multi-annual funding. The Minister for Finance, Deputy Cowen, arranged for multi-annual funding for disability, which was welcome. What has Dr. Gallagher's feedback been on that matter? It seems to me that if funding is insufficient, it will not be possible to do any of these things. Funding is the fundamental bedrock required.

I hope Dr. Gallagher will not take offence at this question, but I do not know whether it is cost effective to have lung transplants in Ireland. Many of our medical procedures are now carried out abroad, so is it worthwhile having lung transplants carried out here? Is there an argument for spreading resources elsewhere? It may be too late to pose such questions but perhaps Dr. Gallagher would care to comment on them.

Perhaps we will bank some questions and I will call on Deputies Neville and Fiona O'Malley to ask some also.

I have a comment to make rather than putting questions because I am a former member of the executive of the Cystic Fibrosis Association of Ireland. One of the biggest fears that people suffering from cystic fibrosis have, is to have to go to hospital because it poses the greatest danger to their lives. Families are in absolute dread of having a family member with cystic fibrosis going into hospital. The report's revelations were no surprise to many of us because the same points have been voiced over the years. Has this matter been discussed with the Minister? Those of us who gave up the fight on this matter many years ago, because we got no hearing, are not confident that anything will happen. Regardless of how many reports were published, nothing has happened over the years. I do not have much confidence that anything will happen about this because of my personal experience in this area.

I thank the members of the delegation for their presentation. Many of the statistics in it were alarming. I am surprised to hear that we have the highest incidence of cystic fibrosis in the world. Is there a geographic or genetic reason for that? What is particular about the Irish in this respect? It was mentioned that CF services in the UK are much better than here but what are the services like in Northern Ireland? What is the rate of incidence of CF in the North compared to the Republic because, presumably, we are all the same people?

Dr. Gallagher said that currently there were 3.3 consultants dealing with CF, while 28 are needed. That is a big difference but I do not suppose he thinks it likely that he will get anything like the 28 consultants required. Are these consultants specialists in cystic fibrosis and, if not, what is the nature of their work? Why did Dr. Gallagher identify that 3.3 consultants were at work in the sector if they are not specialists in that area? Presumably, one could say that more than 3.3 consultants are available, although I do not know if they are specialising in this area. It is worrying to hear how dangerous the situation is for people who are likely to contract cystic fibrosis.

Perhaps we can take those questions now and in the next tranche we will have questions from Senator Quinn, Senator Glynn and Deputy O'Connor.

I will start with a few of these questions and then pass others to my colleagues. On the first question from Deputy McManus about multiple hospitals, the Pollock report was an external review by a UK health care expert, who has recommended that we have a network of hospitals in Ireland which would be both adult and pediatric. They are the current hospitals, not new ones. The report recommends a network of units for pediatric and adult care, with outreach care in other smaller hospitals. As part of this plan that was discussed beforehand, the report not only clearly outlines the problems but states this is what should happen based upon current practice in the UK and Europe and the international guidelines. I hope that answers the Deputy's question, that it looks specifically at hospitals. For example, St. Vincent's Hospital is the national referral centre for adults and there would also be resourcing for adult units in Galway, Cork, Waterford and Limerick, with smaller satellite units elsewhere, in order that the treatment would be planned on a national basis.

The Deputy's next question on community health or hospital based treatment is an important one. I would make the point that cystic fibrosis is so severe it is like having leukemia for life. There is a major focus on community health where appropriate but when people become acutely sick with a severe infection, in most cases they need to come into hospital or, if it is mild, have intravenous treatment at home. For the vast majority of people where it presents as a significant disease, it is like having leukaemia for life.

Our main focus is to keep them out of hospital. It has been shown internationally that this is not possible unless one has the basic resource in hospitals. While there is community involvement, it must be organised in the same way as with leukemia units and that is what happens. Many good general practitioners are actively involved in the care of patients throughout Ireland but the care is co-ordinated for a variety of reasons, one being, for example, that there is a significant incidence of sudden death among those with cystic fibrosis due to a number of rare complications.

If I am correct, the next question related to money. As I understand it, the Deputy asked have we received any sign of getting it. With all due respect, I suppose that is why we are here today. A report has been published since February. The report was detailed and specific and contained a great deal of analysis on this, but the punch line is that Ireland has a dangerous service which is found nowhere else in Europe.

The report also states clearly that the current position on infection control is a medical hazard but also a legal liability, and could be comparable to that of hepatitis C if an outbreak occurs. That is on the public record since last February.

We have received many supportive comments, from the HSE in particular. My own personal view — I am not a politician — is that we need a commitment from Government to release the funding. The level of funding we are talking about is significant but would deal with this problem now. We believe it is attainable with the support of the committee. In particular, we are talking about asking, if the committee agrees, to have it included in the Estimates for 2006. Things can be done now with a number of specific entities. For example, we have had limited money given in one hospital, but we have not had the ceiling on staff raised and therefore we cannot appoint. If the money is made available, things can begin to change next month. This is one case where the issue at present is money. We have people to take up jobs. At present, what it means is that it is shown internationally that somebody with cystic fibrosis coming into a hospital such as St. Vincent's Hospital, or one in Galway or Cork, should be in a single room because he or she can pick up from anybody else bugs which would not make others sick. At present, patients are not placed in such units and they are picking up other bugs. If we had those resources, it would be dealt with now.

The Deputy raised an important point about the fear of hospitals among cystic fibrosis patients. Unfortunately, that is largely an Irish phenomenon. The fear is because of the inadequate resources. Looking across the water to the UK and at Belfast, we see people who we know do not like hospital come in to units which are designed for them. The care of cystic fibrosis now, as I stated previously, is the worst in Western Europe. Nowhere else comes close. The fear the Deputy articulated is correct but it arises from the lack of resources. If we had the resources, we would have a different attitude.

My understanding is there is a meeting scheduled for the Cystic Fibrosis Association of Ireland with the Minister in October. We are grateful for this and we are looking forward to meeting the Minister. I repeat that we appreciate the committee's support today but we need a great deal of support stating this is a priority issue.

Deputy O'Malley raised an important point in asking why the incidence is high. It is highest in the Republic of Ireland. The reasons are not clear but, historically, there is evidence that being a carrier of the cystic fibrosis gene protects one from diarrhoeal illnesses, that is, illnesses which involve severe diarrhoea. My suspicion, which cannot be confirmed, is that cystic fibrosis carriers at the time of the famine 150 years ago were more likely to live than those who were not and being a carrier was protective. That is supposition. The incidence is higher. It is higher than in the North of Ireland and that is a political issue as much as anything else.

The Deputy raised an important point about services in the UK versus in the North of Ireland. On crossing the Border, care for cystic fibrosis is provided night and day. For example, the unit in Belfast has half the number of patients of the unit in St. Vincent's hospital. The Belfast unit has three cystic fibrosis consultants and single rooms. None of that applies anywhere in the South. The level of care provided today in the North is better than that provided here. The level of care that they had ten years ago exceeds the care we can give now, in terms of facilities but also personnel. Let me give one example of what that means which relates to the Deputy's next point. Most hospitals in Ireland with cystic fibrosis consultants would have one consultant. In many places the consultants will not take holidays or if somebody is away on holidays, there is no consultant providing coverage. That would never happen in the UK. We have 3.3 consultants. This means that we have a number of consultants who spend one tenth of their time on cystic fibrosis.

Cystic fibrosis is both an adult and a pediatric disease. There are respiratory consultants in adult care trained in cystic fibrosis. Similarly there are such consultants in pediatrics. I acknowledge that there are other people who help out but the position is similar to that with leukaemia where we would not want our children with leukaemia looked after by somebody who is not trained in that area. We need to have such care as is provided internationally, in Europe and in the UK. When one visits their units, they have people who are trained in that area. We do not have that in Ireland, apart from a total of 3.3 people who are specialised.

I am speaking on behalf of the group and I will be quiet now, but I hope I have answered some of these questions. I would return to the basic point, that many people have come to accept a level of care and being afraid of going to hospital. The figures show that the care in the North of Ireland is superior. Clearly outlined guidelines of what should happen were published. The UK meets them. The North of Ireland meets them. Ireland does not come near meeting any of the criteria. We have the worst cystic fibrosis care in Western Europe.

Ms Mary Lane Heneghan

As the committee will be aware, the association is a support for persons with cystic fibrosis and was established in 1963. We would see ourselves as having a duty of care to all persons with cystic fibrosis. Following on from that, we commissioned the Pollock report, the results of which we are here today to discuss with the committee.

At the simplest level, we are looking for the best possible care that we can get for the life cycle of the person with cystic fibrosis, regardless of where he or she lives and irrespective of the number of years concerned. We would like to have the centres we mentioned. I take Galway as an example or microcosm of what is happening in the rest of the country. Galway has a good paediatric service with a dedicated team, which while not adequate is sufficient to keep the service going. However, it has no adult service. Currently, adults are treated by a paediatrician, which is by no means satisfactory. We seek an adult clinician with training in cystic fibrosis and an understanding of the illness. Dealing with cystic fibrosis is time-consuming and does not just involve a normal visit to the doctor but takes many hours.

Some 45% of persons with cystic fibrosis are adults. This is great and is a sign of the excellent treatment they get at paediatric level. We expect to have more adults in this category in the future or to reach a stage where half the cystic fibrosis patients are adults. There was no planning for this area because adults were probably not part of the profile in the plan. Children with cystic fibrosis now reach adulthood with relatively good health, but when they move into an adult hospital they probably need more specialist care.

The main objective of our presentation is to highlight the deficiencies in the system and to seek support. We have received much good will. We met most members of the committee in June in Buswell's Hotel and we appreciate them asking questions in the Dáil and following up the matter with us. We need action now and need funding from the 2006 budget.

I will allow members to ask questions and will then come back to Ms Heneghan.

I welcome the delegation to the committee. I have known something about cystic fibrosis for some time, mainly from the point of view of the work the association does in raising money. I will focus on that aspect initially. The association puts in a great effort in raising funds and is recognised by the public for this. Perhaps today's meeting will help to broaden that.

Will the delegates explain to us how the money is spent? My imagination was caught by hearing there is no cure for cystic fibrosis. Of the money collected anywhere in the world, is any of it spent on trying to prevent cystic fibrosis or to find a solution? I think of the solution to one of the world's problems — give a man a fish and you feed him for a day, but teach a man to fish and you feed him for life. It seems there will be a never-ending need for money if all the funds are spent on treatment. Is there anywhere an effort is being made to prevent rather than just treat cystic fibrosis?

I welcome the Cystic Fibrosis Association of Ireland delegation to the committee. Deputy McManus touched on the matter of lung transplants. It is good to see we have the expertise to carry out these transplants in Ireland, and the delegates mentioned three for this year. What is the situation with regard to the availability of lungs for transplant? I see an important role for the national treatment purchase fund in this area — perhaps Deputy McManus had this in the back of her mind. Has the association drawn on the fund or has it been used in this regard? Will the association tell us more about screening? What support systems are there for parents of children with cystic fibrosis, apart from the CFAI? Is there any other support group?

Like my colleagues, I will be brief. I welcome the delegation. It is important to echo what was said earlier. Sometimes the system can be frustrating and even listening to just some of the contributions we hear in committee could make one very depressed. However, we should understand the merit of these encounters which are a good idea. I believe strongly in the work of the joint Oireachtas committees where groups get the opportunity to highlight their work, concerns and difficulties. We all, I hope, subscribe to the belief that this process is an important part of the democratic institution.

Two sisters of a young man who visited my clinic a few nights ago died recently. He raised issues about Tallaght Hospital and the gaps he saw in the service when they had to go to St. Vincent's Hospital for treatment. Has the association an interest in that issue? I do not want to be parochial, although I represent Tallaght. The Tallaght Hospital is a fine institution. I am keen to ensure that whatever facilities are required are provided there, but there seems to be a particular gap in this regard.

I wish the association well in its efforts. Sometimes people are sensitive about Government backbenchers because they support Government. However, that does not stop us from being independently minded and supporting what is right. As far as the Cystic Fibrosis Association of Ireland is concerned, we all wish to support it in its needs. I certainly intend to do that.

I will lead off, but please tell me if I miss out on some of the questions. Senator Quinn raised the important question of researching a cure for cystic fibrosis and asked how our funds are spent. There has been enormous effort throughout the world in researching cystic fibrosis, in particular in seeking a cure. In Ireland and throughout the world many millions of euro and dollars have been spent on that holy grail. That work is ongoing and researching a cure is a major focus of the CFAI research programme. The research carried out has shown how to improve quality of life and life expectancy. In many countries, many more people now live into their 40s, 50s or 60s with better treatments for cystic fibrosis. Twenty years ago these people would have died. Research has made a major contribution to teasing out what helps.

At this point, we understand what causes cystic fibrosis. We understand gene mutation, but we cannot yet fix it. When the gene was discovered in 1989, a number of people said that now they knew the gene, they had a cure for it. A number of my colleagues in America said that they could cure cystic fibrosis within five years. That has not happened and is nowhere near happening. In this situation, while understanding is necessary for treatment, it does not provide the cure. To date, the gene treatments available have not been beneficial.

We want to see a cure and are fighting for it, but we are in a situation where we cannot wait for it. We know that providing treatment today will improve quality of life and keep people out of hospital. I will return to the analogy with leukaemia. We want to be able to prevent leukaemia, but cannot do so. However, as a country and community we have invested in resourcing leukaemia units. While we want to find a cure for it, we must treat it on a daily basis. The association's money is spent in a number of ways, with a major focus on research into cystic fibrosis and finding a cure to improve the quality of life for sufferers. I would love to see a cure and not have to be here today, but we still have people that need treatment. We know from research what treatment works. The problem is that we do not have the personnel or facilities to give the treatment we know works, treatment that is given in the North and in the rest of the United Kingdom.

Lung transplantation is very complex but a programme has now been set up and is working and three patients have been treated to date. The issue of resourcing is one which has been decided. It is known that the number of patients from Ireland undergoing transplantation abroad is insufficient and my understanding is that the Government has set up this programme which is in its infancy. Time will tell whether it will be successful but we are very supportive and hope it will be successful. Transplantation is a little like calling the fire brigade when the whole city has burned down. We know that the provision of proper treatment will mean transplantation will be less necessary. It is the end stage, from which we want to keep people away.

While the national treatment purchase fund has many strengths, it does not and cannot operate for cystic fibrosis patients because their treatment is very complex, life-long and involves a team approach. In most cases the teams required are not in place in public hospitals and are definitely not in place in the private sector. Cystic fibrosis treatment is very intensive and not an area to which patients will move unless the necessary infrastructure is in place.

On the issue of screening, in Ireland one in 20 healthy people is a carrier. Therefore, the ratio is one in 1,600 live births. One in 20 healthy people is a carrier of one gene. Two genes from two individuals are required for someone to be born with the disease. Because it is recessive the ratio is one in 1,600 live births. As screening will ensure detection at an earlier stage when treatment can be effective, it is, therefore, very important.

No. I did not make myself clear. Screening is used to detect the disease in newborn babies. The idea is to screen newborn babies for cystic fibrosis and treatment is commenced at an early stage before major symptoms develop. This is not screening for carriers of the disease but for those with it.

I ask Dr. Gallagher to clarify that statement. Are they treated before they present with symptoms?

Very often the symptoms with which they present in infancy are non-specific and it is often a year before they can be diagnosed. The use of screening would allow the disease to be diagnosed. Treatment could then begin before they develop major symptoms.

Does Dr. Gallagher envisage that all newborn babies would be screened?

I thought cystic fibrosis was picked up very early. I live in County Sligo and I am familiar with the disease because some of my friends have children with cystic fibrosis who were diagnosed at a young age, at two and three months, but obviously that is not always the case.

Not all are picked up early. The majority are diagnosed before the age of five years but every year we diagnose people in their teens and in the last year three people in their 40s were diagnosed. Most, but not all, are diagnosed at a young age, which would be preferable. Screening is only practicable if the facilities are in place to treat patients when diagnosed. We have neither the necessary staff nor the infrastructure to treat those who have been diagnosed.

Is any screening carried out?

There is no screening of newborn babies for cystic fibrosis. It is carried out in the North, Britain and elsewhere in Europe.

Is it difficult to do?

No, it is not. It is a fairly simple test carried out on newborn babies and the results are available within several weeks.

It seems extraordinary that the procedure is not part of the examination of newborn babies carried out in maternity hospitals.

This has been approved by a Department of Health and Children sub-committee but there has not been a translation from approval in principle to approval in practice. It needs to be organised on a national basis to allow for appropriate follow-up and treatment once a diagnosis is made.

Mr. Fletcher

The HSE issued a report in January which recommended the establishment of a neonatal screening programme but the final findings of the current working group must be awaited before any further decision is made on the issue. It is hoped a neonatal screening programme will be included.

Dr. Gallagher has stated a person in their 40s was diagnosed with cystic fibrosis. Is it possible to have the disease without presenting with any symptoms?

It is a minority. Most are diagnosed before they are one year old and definitely before they reach the age of five years. However, some may have a mild variant and their symptoms may have been classified as something else.

Mr. Rory Tallon

I am 34 years of age, in full-time employment and have cystic fibrosis, on which there is no shortage of scientific and medical research being conducted globally. The association funds research programmes in Ireland. My primary need is the provision of services. While I am fortunate to have cystic fibrosis in mild form, I will periodically have acute exacerbations and require hospitalisation. Because of the level of cross-infection and the lack of single cubicles I am frightened to go into hospital. I require a complex treatment involving a cocktail of antibiotics and certainly need to be under the care of a consultant rather than a junior registrar. I need to see a wide range of CF care professionals, ranging from physiotherapists and dietitians to specialised nurses. There is no specialist CF ward in St. Vincent's Hospital. If I am lucky, I will be given a bed in the respiratory ward where I will share services with elderly geriatric patients; if I am not so lucky, I will end up in another ward where the nurses will not have received specialist CF training. I would be quite anxious, almost frightened, if I had to go to hospital now.

How many times has Mr. Tallon been hospitalised in the past five years?

Mr. Tallon

Twice.

I am interested to hear of Mr. Tallon's experience. I refer to the case of a young girl who was moved from the child to the adult treatment service. As a child, she had a good experience but when she needed to go to hospital, she was admitted through the accident and emergency department and placed on a trolley beside a person who had MRSA. Is this the normal admittance procedure for an adult with cystic fibrosis who requires regular check-ups? If so, it is unacceptable.

Mr. Tallon

Unfortunately, it is becoming the norm. In the first of my last two hospitalisations there was no bed available in the respiratory ward and I ended up in the diabetic ward, a three-bed ward in which one of the patients had MRSA. I requested to be moved immediately. My second admission to hospital was as a result of an injury acquired pleural fusion and I was in a lot of pain. I spent 12 hours in the accident and emergency department of St. Vincent's Hospital before being admitted to a ward.

Can the committee propose to the HSE that people with cystic fibrosis should not be admitted to hospital through accident and emergency units? I appreciate that there are problems with the number of beds available. The person in the case I mentioned was attending St. Vincent's Hospital. It is completely unacceptable that people with cystic fibrosis who are so susceptible to infections are asked to go to accident and emergency departments. I apologise for arriving late at this meeting, but I was here in time to hear Ms Lane Heneghan who is from Galway speak about the adult service in the west. How many adults in the west have cystic fibrosis? Ms Lane Heneghan spoke about the good service provided by paediatricians. That is also the case in my local hospital which employs a very good paediatric consultant who has an interest in cystic fibrosis. The service is not enough, however. How many sufferers are there? Can the committee propose to the HSE that an adult cystic fibrosis clinician be employed in each of the regions?

I welcome the representatives of the Cystic Fibrosis Association of Ireland. I thank the Chairman for allowing me to speak, as I am not a member of the committee.

I was alarmed to hear Deputy O'Malley say she was just a little alarmed to hear of the staffing levels outlined to the committee this morning. A level of understaffing of 438% is most alarming. A person who says it is a little alarming does not appreciate the situation or understand the information put before us this morning. There is no point in wondering why the incidence of cystic fibrosis is higher in the Twenty-six Counties than in Northern Ireland — that is for another day. It would probably be more useful to dwell on why the services in Northern Ireland are much better than those in this jurisdiction. One of the speakers said a great deal of goodwill was being shown to the Cystic Fibrosis Association of Ireland, but goodwill is not worth a damn. Meaningful decisions need to be taken at the appropriate level in a way that makes a major impact on the work of the association which for many years has been doing its business on a shoestring budget.

The nub of the problem is that the people represented by the association have been deprived of services which should have been provided a long time ago. It is fair enough to talk about whether research is being done in certain areas, but it would be better to discuss such matters on another day. The representatives of the association have been invited to this meeting to impress on everyone who is willing to listen the need for urgent and immediate funding. It is timely and appropriate that the association has presented itself before the Joint Committee on Health and Children to make its case at a time of the year when officials are starting to prepare the Estimates and the Minister for Finance is formulating his budget. As I am not a member of the committee, I do not intend to tell the committee what to do. However, it would be most useful for it to make a presentation to the Minister, highlighting the urgency of the situation and asking for appropriate funding to be made available. It would also be a good idea to make representations to the HSE. We need to focus on why the representatives of the association have come to this meeting. We can talk about long-term issues when the budget has been finalised and additional funding has been allocated, but our immediate priority should be to make the case for immediate action to the Minister and the HSE ahead of the forthcoming budget.

I apologise for arriving late. Like other speakers, I welcome the delegation from the Cystic Fibrosis Association of Ireland. I have attended a few meetings of the committee, at which all of its members have been singing from the same hymn sheet in the presence of groups such as the association. We have all been impressed by its presentation and all support the case made. We will lobby hard for adequate provisions to be made for the association during the upcoming Estimates process. I second Deputy Cooper-Flynn's proposal that the committee recommend that people with cystic fibrosis should not be admitted to hospital through accident and emergency departments.

I would like to add a proviso, that additional beds have to be made available.

Absolutely. It is implicit in the proposal that people with cystic fibrosis should be sent to a more appropriate facility, rather than just being sent away.

We need to make additional beds available.

Having listened to Mr.Tallon's comments, it is clear that it is not acceptable, from a physical and medical health perspective, for people with cystic fibrosis to have to wait in an accident and emergency unit beside a person from whom they might pick something up.

I would like to make a few comments and ask a few questions. I am sorry that I do not have the Pollock report to hand, although I have considered some of its recommendations. The second recommendation is that a small number of adequately staffed and fully supported cystic fibrosis centres be designated. I assume, on the basis of the comments made today, that some such units have been put in place. Where are they located? What kind of standard applies to them? The Cystic Fibrosis Association of Ireland has been kind enough to acknowledge that the provision of a small amount of emergency funding was a kind gesture. Some €300,000 was donated, which is peanuts. What was the association able to do with that money? What did it get from it?

All public representatives have been touched by our meetings with the parents of children who have cystic fibrosis. I have encountered the sad case of a family with four young children, two of whom suffer from cystic fibrosis. When the two little boys with cystic fibrosis go to hospital with their mother, the other two children have to be minded by someone else because their father is at work. What does the association think about the possibility of giving medical cards to cystic fibrosis sufferers, regardless of whether they are children or adults, even if they do not fall into the medical card income bracket? Would it make a difference? I know it would.

Dr. Gallagher spoke about the search for a cure for cystic fibrosis. I know the heavens open and we are all damned to hell every time we talk about stem cell research. Will Dr. Gallagher give the joint committee a brief overview of recent developments in international research in this area? I appreciate his admission that the best we can do is to treat for today, because we have not made progress in other respects. I did not fully understand his comments about the type of treatment offered in Northern Ireland. He seemed to suggest that we did not or could not offer such treatment in this jurisdiction. Will he elaborate on what he meant by this?

Deputy O'Malley spoke about the diagnosis of cystic fibrosis among people in their 40s. Dr. Gallagher has said it is sometimes not noticed because it masks itself as some other ailment or medical problem. It is obvious from Mr. Tallon's comments about being hospitalised twice in the space of five years that the level of suffering varies among people with cystic fibrosis. Is the variation in suffering caused by a lack of treatment? Do certain people suffer more, simply because they were born with worse problems in their lungs?

I would like to ask about the provision of services. Mr. Tallon spoke about the need for single units or cubicles to minimise the risk of picking up cross-infections. How important is it for him to return to the same consultant many times? Is it considered important to build a relationship with a consultant? I appreciate that he might prefer to deal with medical personnel other than junior registrars because they change so often, especially in training hospitals.

I agree with Deputy McHugh that it is alarming that just 3.3 consultants are employed, even though 28 are needed. Given that many medicine graduates travel abroad to participate in specialist training programmes, would it be realistically possible if sufficient funds were available in the morning to acquire the medical manpower to put 28 consultants in place? As there are very few places to access in Ireland, people tend to travel to undergo this type of training. I ask if they will come back, especially given the position on the common contract.

I apologise for being late, especially as I had agreed to be here for the morning. As I have not been present for the last hour, I am making certain presumptions in picking up on pieces of the Pollock report which I had an opportunity to read. I acknowledge the sense of urgency, especially on staffing levels. Staff numbers to provide linchpin services for cystic fibrosis sufferers, including nurses, physiotherapists, dietitians and psychologists, were described as completely inadequate at 400% below minimum acceptable standards. As Deputy McHugh said, the matter is more urgent than we realise. I read last Tuesday's health supplement to The Irish Times in which an article was devoted to this issue. I examined Mr. Carl Rainey’s overview of what members have realised this morning and must acknowledge is a crisis. I support Deputy Cooper-Flynn’s point that we should try as we enter the pre-budget Estimates debate to recognise the difficult issue we face. We can only do this by focusing on the number who suffer from cystic fibrosis. The figure is alarming at 1,143. In reading that the incidence is one in every 1,600 births compared with one in every 25,000 in Finland, we must acknowledge not only the inadequacy of staff numbers but of financial resources. Clearly, the demands on the Department will escalate unless we begin to realise we must deal with the issues in question now.

I will not go back over ground which has been well covered except to say I would like the committee to embrace the key points made in Mr. Pollock's report and realise that they must be the focus of our attention. It has been alarming, to use the weakest word I can conjure, in the debate on MRSA to discover the significant difficulties which were encountered pre-MRSA by cystic fibrosis patients. Given the complete inadequacy of the current facilities, the problem will only grow worse. This is one of the most significant issues which has come before the committee in the past two years. We will offer support, not only in words, but also by ensuring the matter is prioritised as the Minister sits down to prepare the Estimates for the budget.

Mr. Tallon

The question of continuity in seeing specialists was raised. While I do not mind personally who I see, I would like to be reassured that I am in receipt of the best treatment which can be delivered in accordance with standard acceptable international practice and being prescribed the right combination of antibiotics, especially where I am hospitalised for an acute exacerbation.

On the subject of cross-infection and the provision of single, isolated cubicles, it is quite common to acquire infections while in hospital. In the cystic fibrosis community, MRSA poses a very significant risk and is pathogenic to CF sufferers. There are other levels of bacterial colonisations which are an issue, some of which are a little more severe than others and specific to cystic fibrosis due to the environment of the CF lung. Globally, there are different standard practice segregation policies. Unfortunately, it is very difficult to implement such policies in Ireland due to the level of care provided. The provision of isolated, single cubicles would certainly meet the requirement and reduce the level of cross-infection from MRSA and other pathogenic CF species and generally acquired hospital infections.

Senator Feeney asked about the importance of a medical card to a person with cystic fibrosis. A medical card would alleviate my dependence on a specialist centre as I would be able to attend a general practitioner if I had a common cold to determine whether I needed to attend hospital to have my level of illness monitored. While a medical card would also provide for other services, including the taking of blood samples and flu vaccines, I would still need to attend specialist centres.

There are units around the country, as summarised in the Pollock report. Specific recommendations were made in the report on recommended centres based on regional needs to provide care close to people's homes and provide for a sufficient number of patients and staff in each. Regional units were recommended for Cork, Limerick, Galway and Waterford with adult and paediatric units in Dublin also. There is a model to allow people to be treated near their homes. The report recommends the establishment of a number of satellite units for a small number of patients. It does not simply point out what the problem is, it provides solutions, which is one of its strengths.

I was asked what was provided for the €300,000 in funding. The money given to St. Vincent's Hospital was partly intended to provide for the hiring of another consultant. As there is a cap on staff recruitment, we do not have approval to hire a full-time consultant on an ongoing basis, despite the provision of ongoing funding. While funding is one of the significant issues, we also have the problem of the cap in this area, unlike in some others. Cystic fibrosis is an area in which the current level of care is grossly inadequate and documented to be so, to an extent seen nowhere else in Europe. As I mentioned, many eastern European countries have a level of cystic fibrosis care which is far superior to that in Ireland. We need to begin to build up the basic structure right now. We are not looking for a Cadillac, but for a Mini that can actually move.

The very important issue of the medical card was raised. Currently, every person with cystic fibrosis is entitled to a long-term disability medical card to ensure they are provided with a certain level of care, regardless of income. The system needs to be standardised.

To address the issue of therapy in Northern Ireland, it is not so much the treatment available, but people and places. We do not have the units or doctors, nurses, physiotherapists and dietitians to provide the care needed. Neither do we have, for example, a single room for Mr. Tallon when he is admitted to hospital. The question is a basic one of staff and resources. The difference between here and Northern Ireland is not the drugs, but the lack of people and places to provide the required level of care. It has been clearly demonstrated, therefore, that quality of life and, probably, survival, are better in Northern Ireland.

If the resources were in place, do we have the trained nursing and medical personnel required?

While we could not recruit 28 consultants tonight, there are many Irish people heading up top-ranked cystic fibrosis centres in Europe and North America. In many cases, they would come back. Within two months of the launch of the report last February, ten people telephoned me from North America to indicate a desire to come back and ask if there would be jobs available. I had to say we would have to wait and see but nothing has changed in the intervening eight months. While we could not fill all posts immediately, we could address the emigration of Irish professionals out of necessity because the jobs required in the area of cystic fibrosis are not being filled. In many, albeit not all, cases we could fill positions immediately.

An important point was made about people in their 40s. There is luck involved with cystic fibrosis. Some people are born with minor forms of the disease and would, therefore, have a relatively good outlook. On the other hand, we also know that the level of care they receive today is not beneficial. Those who receive optimum care in their teens and 20s will be in better health in their 40s and live longer than they would have otherwise. One's health depends on a number of factors, including the degree of cystic fibrosis one is born with and this is a complex issue encompassing genes, gender and so forth.

It is noteworthy that in general women with cystic fibrosis fare worse than men with the disease, although there are many exceptions to this general rule. While the form of disease one is born with is important, it has been shown throughout the world that the treatment one receives is the single most important determinant of outcome, more important than any gene or other factor.

To address the important points raised about accident and emergency services, this takes us back to the core issue. Until we have the units and staff required to care for people with cystic fibrosis, they will continue to find it necessary to attend accident and emergency departments. Cystic fibrosis is not an accident and emergency issue. Ireland does not have sufficient hospital beds for cystic fibrosis patients and for this reason people with the disease attend accident and emergency departments.

To summarise, the Cystic Fibrosis Association of Ireland seeks support from the joint committee in addressing the problems we face in the manner outlined in the Pollock report and, in particular, a supplement issued by the association last February. We will circulate this supplement, which features a photograph of Carl Rainey, after the meeting. The supplement states we want two issues addressed, namely, delivery of a national service providing care, including the recruitment of staff, and physical resources in the units in St. Vincent's Hospital and throughout the country. This is a national issue and must be addressed as such.

These issues can be dealt with by approving €30 million in funding. If this figure was approved, we could start recruiting staff today because people are already seeking these jobs. We could quickly make a significant difference in this area of health if funding was approved. I will get down from the pulpit. I hope I have answered some of the questions Members put to us on behalf of the group.

Mr. Carl Rainey

I would like to comment on Deputy McHugh's perceptive comments. We need resources, which in this case means money. This issue boils down to a commitment to money. The Cystic Fibrosis Association of Ireland has lobbied for many years to secure the required resources. Eventually, we went to the trouble and expense of getting an international expert, Dr. R. M. Pollock, to examine the issue and produce a report. We have met Ministers, heads of hospitals and so forth over the years but they have paid lip service to meeting our demands. The Pollock report highlights what we need, which is money. We urge the joint committee to ask the Minister for Health and Children to make the resources we seek a priority in the forthcoming budget and fund what is needed immediately.

Why is the number of people with cystic fibrosis greater here than elsewhere?

To have cystic fibrosis one must have a gene from both parents. The frequency of carriers is much greater in Ireland than in other parts of the world but it is also high in the United Kingdom and the North. The probable reason it is higher here is that being a carrier also has a protective function and the gene may protect one from certain illnesses, for example, those which arise during famine.

I thank the delegation for attending today and making a detailed presentation. Members have been highly impressed by the presentation and the joint committee will make representations to the Minister and the Health Service Executive in support of the case made today by the Cystic Fibrosis Association of Ireland. Is it correct that a delegation from the association will meet the Minister for Health and Children, Deputy Harney, in the near future?

Ms Lane Heneghan

Yes, we will meet her in October.

The delegation can rest assured that our presentation will be on the Minister's desk before that meeting. Is that agreed? Agreed.

Sitting suspended at 10.55 a.m. and resumed at 11.05 a.m.
Barr
Roinn